Mourad Tayebi is currently Professor in Biomedical Sciences at the School of Medicine, Western Sydney University, AUSTRALIA. Mourad Tayebi was awarded a PhD in Neuroimmunology from Imperial College. Previously, he worked as Senior Research Fellow at the University of Sydney before returning to the UK and accepting an academic position at the University of London leading a team of scientists with a specific focus on protein misfolding diseases. He was offered a Faculty position at UT Health where he led a team of scientists interested in investigating the molecular mechanisms underlying protein misfolding/aggregation. Dr. Tayebi is an international expert in the field of PROTEIN MISFOLDING DISEASES, with specific focus on investigating the molecular mechanisms underlying pathogenic protein misfolding and characterizing the misfoldome associated with these disorders. Dr. Tayebi’s team is very active in the development of early diagnostic test screen for Alzheimer and effective therapies for neurodegenerative diseases. His research focuses on refining the therapeutic strategies through developing novel antibodies that would specifically recognize the oligomeric forms of misfolded proteins. His team developed a panel of camelid antibodies able to transmigrate across the blood-brain barrier and enter the cell membrane of neurons.